Amgen Valuation
| AMGN Stock | MXN 4,651 201.54 4.53% |
At this time, the firm appears to be fairly valued. Amgen Inc shows a prevailing Real Value of 4776.74 per share. The current price of the firm is 4651.04. Our model approximates the value of Amgen Inc from analyzing the firm fundamentals such as profit margin of 0.25 %, and Return On Equity of 1.26 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Amgen's price fluctuation is very steady at this time. Calculation of the real value of Amgen Inc is based on 3 months time horizon. Increasing Amgen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Amgen Inc is useful when determining the fair value of the Amgen stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Amgen. Since Amgen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amgen Stock. However, Amgen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4651.04 | Real 4776.74 | Hype 4651.04 |
The real value of Amgen Stock, also known as its intrinsic value, is the underlying worth of Amgen Inc Company, which is reflected in its stock price. It is based on Amgen's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Amgen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amgen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amgen Inc helps investors to forecast how Amgen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amgen more accurately as focusing exclusively on Amgen's fundamentals will not take into account other important factors: Amgen Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Amgen's current stock value. Our valuation model uses many indicators to compare Amgen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amgen competition to find correlations between indicators driving Amgen's intrinsic value. More Info.Amgen Inc is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies fabricating about 0.15 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Amgen Inc is roughly 6.63 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amgen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amgen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amgen's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Amgen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Amgen and how it compares across the competition.
About Amgen Valuation
The stock valuation mechanism determines the current worth of Amgen Inc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Amgen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Amgen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Amgen's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Amgen's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amgen. We calculate exposure to Amgen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amgen's related companies.Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. AMGEN INC operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 21500 people.
8 Steps to conduct Amgen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Amgen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Amgen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Amgen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Amgen's revenue streams: Identify Amgen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Amgen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Amgen's growth potential: Evaluate Amgen's management, business model, and growth potential.
- Determine Amgen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Amgen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |